Portrait der Gilead Sciences Aktie
Das Unternehmen Gilead Sciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Gilead Sciences ist in mehr als 83 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Gilead Sciences mit 7,06% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Gilead Sciences Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Gilead Sciences am höchsten gewichtet ist Insgesamt in 83 ETFs enthalten
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
325 News & Informationen zur Gilead Sciences Aktie
3 Biotech Stocks That Could Make You Richer in August (and Beyond)
All three have blockbuster products already on the market.
Pre-clinical data on HOOKIPA’s arenaviral immunotherapeutic in melanoma published in Nature Communications
HOOKIPA’s arenaviral platform technology demonstrated ability to modulate the tumor microenvironment and induce potent melanoma-specific T cell responsesA…
Torray LLC Buys VMware Inc, Fiserv Inc, KLA Corp, Sells Oracle Corp, The Kraft Heinz Co, Motorola Solutions Inc
GuruFocus Article or News written by insider and the topic is about:
Gilead Sciences : Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
Gilead Sciences, Inc. today announced a more than $200 million endowment to the Gilead Foundation to further the company's vision of creating a healthier world for all people. The Gilead Foundation,… | August 3, 2021
Gilead Sciences Endows Its Foundation With More Than $200 Million To Support Health Justice, Community Giving And Employee Match Program
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a more than $200 million endowment to the Gilead Foundation to further the company's vision of creating a
Assembly Bio Announces Key Promotions To Leadership Team
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing
TriaGen Wealth Management LLC Buys Constellation Brands Inc, Sherwin-Williams Co, Direxion Auspice Broad Commodity Strategy ETF, Sells Dollar Tree Inc, Diodes Inc, CME Group Inc
GuruFocus Article or News written by insider and the topic is about:
Why Investors Should Like BioNTech's Latest Deal With Gilead
There are several pluses for BioNTech in the deal.
Symons Capital Management Inc Buys Apple Inc, Kimberly-Clark Corp, American Electric Power Co Inc, Sells JM Smucker Co, U.S. Bancorp, The Kraft Heinz Co
GuruFocus Article or News written by insider and the topic is about:
Investment Management Associates Inc Buys Diamond Hill Investment Group Inc, Dropbox Inc, Black Stone Minerals LP, Sells Invesco, Janus Henderson Group PLC, Patterson Inc
GuruFocus Article or News written by insider and the topic is about:
Here is a Market Recap for today Friday, July 30, 2021 : stocks
PsychoMarket Recap – Friday, July 30, 2021 Stocks fell Friday, reversing after yesterday’s gains to cap off one of the choppier weeks we’ve had in …
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…
Stocks making the biggest moves midday: Amazon, P&G, Caterpillar and more
These are the stocks posting the largest moves in midday trading.
Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades – 24
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including Amazon.com, Edwards Lifesciences, Gilead Sciences, Mastercard and Pinterest.
Gilead Sciences Q2 Revenues Grow 21 Percent as CAR T-Cell Business Jumps 39 Percent
Revenues from pharmaceutical products were almost entirely driven by the COVID-19 treatment remdesivir, though sales of Kite Pharma's CAR T-cell therapies grew, too.
Stocks making the biggest moves premarket: P&G, Exxon Mobil, Chevron, Caterpillar and others : StockMarket
Procter & Gamble (PG) – The consumer products giant rose 1.1% in the premarket after it beat estimates by 5 cents with quarterly earnings of $1.13 …
This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer
Pfizer is ready to take on a second coronavirus market.
Gilead Sciences, Inc.'s (GILD) CEO Daniel O'Day on Q2 2021 Results – Earnings Call Transcript
Gilead Sciences, Inc.'s (NASDAQ:GILD) Q2 2021 Results Earnings Conference Call July 30, 2021, 04:30 PM ET Company Participants Jacquie Ross – Vice President Investor Relations Daniel O'Day…
Gilead Sciences, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:GILD)
The following slide deck was published by Gilead Sciences, Inc.
GILEAD SCIENCES : ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)
U.S.
86
90
175
162
… | July 29, 2021
IGM Biosciences Announces The Appointment Of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., As Chief Medical Officer
MOUNTAIN VIEW, Calif., July 29, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and
Gilead Sciences : COVID-19 drug sales help boost Gilead 2nd-quarter results, HIV sales dip
Gilead Sciences Inc on Thursday
posted higher-than-expected second-quarter earnings, helped by
strong demand for its COVID-19 antiviral treatment, Veklury,
but sales of its flagship HIV drugs lagged… | July 29, 2021
Gilead Sciences tightens 2021 guidance; remdesivir sales slide (NASDAQ:GILD)
Gilead Sciences (GILD) is trading ~2.1% lower in the post-market despite beating expectations with its revenue and adjusted EPS in Q2 2021 financials.Total revenue has risen 21%…
COVID-19 drug sales help boost Gilead 2nd-quarter results, HIV sales dip By Reuters
COVID-19 drug sales help boost Gilead 2nd-quarter results, HIV sales dip
Avalon Advisors, Llc Buys Gilead Sciences Inc, Intel Corp, FedEx Corp, Sells Albemarle Corp, Garmin, The Estee Lauder Inc
GuruFocus Article or News written by insider and the topic is about:
Gilead Sciences : View Second Quarter 2021 Supplementary Info
CONDENSED CONSOLIDATED BALANCE SHEETS
… | July 29, 2021
Gilead Sciences EPS beats by $0.12, beats on revenue (NASDAQ:GILD)
Gilead Sciences (GILD): Q2 Non-GAAP EPS of $1.87 beats by $0.12; GAAP EPS of $1.21 misses by $0.22.Revenue of $6.22B (+21.0% Y/Y) beats by $140M.FY21 Guidance: Total product sales…
Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30
/PRNewswire/ — DelveInsight's Crohn's Disease (CD) Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Crohn's…
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
Unigestion Holding SA Buys Microsoft Corp, Canadian Imperial Bank of Commerce, Facebook Inc, Sells Gilead Sciences Inc, Walmart Inc, C.H. Robinson Worldwide Inc
GuruFocus Article or News written by insider and the topic is about:
This Biotech Stock Is Too Cheap to Ignore
Wall Street's short attention span has created an attractive entry point in this once-loved biotech.
Can Nurix's Anticipated Milestones Boost Its Share Price?
Shares of Nurix Therapeutics Inc. (NRIX) are down 37% from their all-time high of $52.38, set on Dec.14, and trade around $32..
Can Nurix's Anticipated Milestones Boost Its Share Price?
Shares of Nurix Therapeutics Inc. (NRIX) are down 37% from their all-time high of $52.38, set on Dec.14, and trade around $32..
Cognizant Technology Solutions (CTSH) Q2 2021 Earnings Call Transcript
CTSH earnings call for the period ending June 30, 2021.
Capital Investment Counsel, Inc Buys Apple Inc, Pfizer Inc, Alphabet Inc, Sells Aerojet Rocketdyne Holdings Inc, , Medical Properties Trust Inc
GuruFocus Article or News written by insider and the topic is about:
A Look Into Gilead Sciences Price Over Earnings
Looking into the current session, Gilead Sciences Inc. (NASDAQ:GILD) shares are trading at $68.78, after a 0.1% increase. Moreover, over the …
Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…
Union Bankshares Corp Buys Vanguard Russell 1000 Growth Index Fund, iShares Russell 1000 Growth ETF, iShares Russell 1000 Value ETF, Sells JPMorgan Ultra-Short Income ETF, Oracle Corp, BTC iShares Int
GuruFocus Article or News written by insider and the topic is about:
Corporate Council on Africa prepares to welcome Heads of State and Global Business Leaders to the 13th U.S.-Africa Business Summit
Preparations for the Corporate Council on Africa (CCA) (www.CorporateCouncilonAfrica.com) 13th U.S.-Africa Business Summit being held virtually on July 27 – 29, 2021 are well under way. The
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…